Androgen receptor gene and sex-specific Alzheimer's disease

Raffaele Ferrari, Saad Dawoodi, Merrill Raju, Avinash Thumma, Linda S. Hynan, Shirin Hejazi Maasumi, Joan S. Reisch, Sid O'Bryant, Marjorie Jenkins, Robert Barber, Parastoo Momeni

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Women are at a 2-fold risk of developing late-onset Alzheimer's disease (AD) (onset at 65 years of age or older) compared with men. During perimenopausal years, women undergo hormonal changes that are accompanied by metabolic, cardiovascular, and inflammatory changes. These all together have been suggested as risk factors for late-onset AD. However, not all perimenopausal women develop AD; we hypothesize that certain genetic factors might underlie the increased susceptibility for developing AD in postmenopausal women. We investigated the Androgen Receptor gene (. AR) in a clinical cohort of male and female AD patients and normal control subjects by sequencing all coding exons and evaluating the length and distribution of the CAG repeat in exon 1. We could not establish a correlation between the repeat length, sex, and the disease status, nor did we identify possible pathogenic variants. AR is located on the X chromosome; to assess its role in AD, X-inactivation patterns will need to be studied to directly correlate the actual expressed repeat length to a possible sex-specific phenotypic effect.

Original languageEnglish (US)
JournalNeurobiology of Aging
Volume34
Issue number8
DOIs
StatePublished - Aug 2013

Fingerprint

Androgen Receptors
Alzheimer Disease
Genes
Exons
X Chromosome Inactivation
X Chromosome

Keywords

  • Alzheimer's disease
  • Androgen receptor
  • Epigenetics
  • Menopause
  • X-inactivation

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)
  • Aging
  • Developmental Biology
  • Geriatrics and Gerontology

Cite this

Ferrari, R., Dawoodi, S., Raju, M., Thumma, A., Hynan, L. S., Maasumi, S. H., ... Momeni, P. (2013). Androgen receptor gene and sex-specific Alzheimer's disease. Neurobiology of Aging, 34(8). https://doi.org/10.1016/j.neurobiolaging.2013.02.017

Androgen receptor gene and sex-specific Alzheimer's disease. / Ferrari, Raffaele; Dawoodi, Saad; Raju, Merrill; Thumma, Avinash; Hynan, Linda S.; Maasumi, Shirin Hejazi; Reisch, Joan S.; O'Bryant, Sid; Jenkins, Marjorie; Barber, Robert; Momeni, Parastoo.

In: Neurobiology of Aging, Vol. 34, No. 8, 08.2013.

Research output: Contribution to journalArticle

Ferrari, R, Dawoodi, S, Raju, M, Thumma, A, Hynan, LS, Maasumi, SH, Reisch, JS, O'Bryant, S, Jenkins, M, Barber, R & Momeni, P 2013, 'Androgen receptor gene and sex-specific Alzheimer's disease', Neurobiology of Aging, vol. 34, no. 8. https://doi.org/10.1016/j.neurobiolaging.2013.02.017
Ferrari, Raffaele ; Dawoodi, Saad ; Raju, Merrill ; Thumma, Avinash ; Hynan, Linda S. ; Maasumi, Shirin Hejazi ; Reisch, Joan S. ; O'Bryant, Sid ; Jenkins, Marjorie ; Barber, Robert ; Momeni, Parastoo. / Androgen receptor gene and sex-specific Alzheimer's disease. In: Neurobiology of Aging. 2013 ; Vol. 34, No. 8.
@article{59928c5b439a4b1f86c909ddc55a7eae,
title = "Androgen receptor gene and sex-specific Alzheimer's disease",
abstract = "Women are at a 2-fold risk of developing late-onset Alzheimer's disease (AD) (onset at 65 years of age or older) compared with men. During perimenopausal years, women undergo hormonal changes that are accompanied by metabolic, cardiovascular, and inflammatory changes. These all together have been suggested as risk factors for late-onset AD. However, not all perimenopausal women develop AD; we hypothesize that certain genetic factors might underlie the increased susceptibility for developing AD in postmenopausal women. We investigated the Androgen Receptor gene (. AR) in a clinical cohort of male and female AD patients and normal control subjects by sequencing all coding exons and evaluating the length and distribution of the CAG repeat in exon 1. We could not establish a correlation between the repeat length, sex, and the disease status, nor did we identify possible pathogenic variants. AR is located on the X chromosome; to assess its role in AD, X-inactivation patterns will need to be studied to directly correlate the actual expressed repeat length to a possible sex-specific phenotypic effect.",
keywords = "Alzheimer's disease, Androgen receptor, Epigenetics, Menopause, X-inactivation",
author = "Raffaele Ferrari and Saad Dawoodi and Merrill Raju and Avinash Thumma and Hynan, {Linda S.} and Maasumi, {Shirin Hejazi} and Reisch, {Joan S.} and Sid O'Bryant and Marjorie Jenkins and Robert Barber and Parastoo Momeni",
year = "2013",
month = "8",
doi = "10.1016/j.neurobiolaging.2013.02.017",
language = "English (US)",
volume = "34",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Androgen receptor gene and sex-specific Alzheimer's disease

AU - Ferrari, Raffaele

AU - Dawoodi, Saad

AU - Raju, Merrill

AU - Thumma, Avinash

AU - Hynan, Linda S.

AU - Maasumi, Shirin Hejazi

AU - Reisch, Joan S.

AU - O'Bryant, Sid

AU - Jenkins, Marjorie

AU - Barber, Robert

AU - Momeni, Parastoo

PY - 2013/8

Y1 - 2013/8

N2 - Women are at a 2-fold risk of developing late-onset Alzheimer's disease (AD) (onset at 65 years of age or older) compared with men. During perimenopausal years, women undergo hormonal changes that are accompanied by metabolic, cardiovascular, and inflammatory changes. These all together have been suggested as risk factors for late-onset AD. However, not all perimenopausal women develop AD; we hypothesize that certain genetic factors might underlie the increased susceptibility for developing AD in postmenopausal women. We investigated the Androgen Receptor gene (. AR) in a clinical cohort of male and female AD patients and normal control subjects by sequencing all coding exons and evaluating the length and distribution of the CAG repeat in exon 1. We could not establish a correlation between the repeat length, sex, and the disease status, nor did we identify possible pathogenic variants. AR is located on the X chromosome; to assess its role in AD, X-inactivation patterns will need to be studied to directly correlate the actual expressed repeat length to a possible sex-specific phenotypic effect.

AB - Women are at a 2-fold risk of developing late-onset Alzheimer's disease (AD) (onset at 65 years of age or older) compared with men. During perimenopausal years, women undergo hormonal changes that are accompanied by metabolic, cardiovascular, and inflammatory changes. These all together have been suggested as risk factors for late-onset AD. However, not all perimenopausal women develop AD; we hypothesize that certain genetic factors might underlie the increased susceptibility for developing AD in postmenopausal women. We investigated the Androgen Receptor gene (. AR) in a clinical cohort of male and female AD patients and normal control subjects by sequencing all coding exons and evaluating the length and distribution of the CAG repeat in exon 1. We could not establish a correlation between the repeat length, sex, and the disease status, nor did we identify possible pathogenic variants. AR is located on the X chromosome; to assess its role in AD, X-inactivation patterns will need to be studied to directly correlate the actual expressed repeat length to a possible sex-specific phenotypic effect.

KW - Alzheimer's disease

KW - Androgen receptor

KW - Epigenetics

KW - Menopause

KW - X-inactivation

UR - http://www.scopus.com/inward/record.url?scp=84877635744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877635744&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2013.02.017

DO - 10.1016/j.neurobiolaging.2013.02.017

M3 - Article

VL - 34

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 8

ER -